ZNF217 promotes receptor tyrosine kinase plasticity and AXL-ERK dependency in ovarian cancer
Megha J. Pandya, Jessica Hoffman, Achuth Padmanabhan
This study identifies ZNF217 as a driver of chemoresistance in ovarian cancer by promoting AXL-ERK signaling plasticity and resistance to ERBB2 inhibitors.
bioRxiv · Sep 14, 2026 · PreprintCancer Biology